title: Acute kidney injury associated with tumor lysis syndrome: a paradigm shift.
authors.forename: Amr
authors.initials: A
authors.lastname: El-Husseini
authors.forename: Alberto
authors.initials: A
authors.lastname: Sabucedo
authors.forename: Jorge
authors.initials: J
authors.lastname: Lamarche
authors.forename: Craig
authors.initials: C
authors.lastname: Courville
authors.forename: Alfredo
authors.initials: A
authors.lastname: Peguero
mesh_terms: D058186:Acute Kidney Injury / Q000097:blood / Q000209:etiology*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D003404:Creatinine / Q000097:blood; D006801:Humans; D033461:Hyperuricemia / Q000139:chemically induced; D016393:Lymphoma, B-Cell / Q000150:complications / Q000188:drug therapy; D008297:Male; D010710:Phosphates / Q000097:blood; D015275:Tumor Lysis Syndrome / Q000097:blood / Q000150:complications* / Q000209:etiology; D014503:Urate Oxidase / Q000009:adverse effects / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood
chemical_list: D000970:Antineoplastic Agents; D010710:Phosphates; C469709:rasburicase; D014527:Uric Acid; D003404:Creatinine; D014503:Urate Oxidase; D002118:Calcium